Polycystic kidney disease comprises a group of genetic disorders caused by mutations in at least 5 genetically distinct genes. The most common form of PKD, autosomal dominant polycystic kidney disease (ADPKD), is one of the most common monogenic genetic diseases (PDPKD) of man, affecting about 1 in 1,000 individuals. ADPKD leads to cystic replacement of renal tissue and progressive renal failure, requiring renal replacement therapy in half of the cases by age 50. It is a systemic disease involving not only the kidney but also the liver, pancreas, arteries and heart. Polycystins comprise a new class of membrane-spanning proteins. To date, four polycystins, encoded by four genetically distinct genes, have been identified. Polycystins -1, and -2, are mutated in autosomal dominant polycystic kidney disease (ADPKD). Polycystins-REJ and -L, which are mostly closely related to polycystin -1 and -2, respectively, are not yet implicated in disease states. The polycystin family can be divided into polycystin-1 (PC1)-like and polycystin-2(PC2)-like subgroups. Both PC2-like proteins (polycystins-2 and -L) share structural homology with cation channels such as those of the transient receptor potential (TRP) and voltage-gated Ca2+, Na+ and K+ channel families. On the other hand, both PC1-like molecules, polycystins-1 and -REJ, share significant domain and sequence homology to a putative ion channel regulator (receptor for egg jelly) in sea urchins. The object of this renewal proposal is to extend the functional studies of polycystin -1 and polycystin-L. Three main lines of investigation will be pursued. First, further characterization of two previously identified potential binding partners of polycystin-1, and continue to search for polycystin-1 ligands. Second, extending the recent studies that show that polycystin-L has channel properties and determine whether other polycystins (1 and 2) modulate these properties. Lastly, complement these biochemical and biophysical studies with gene targeting experiments to elucidate the biological functions of polycystin-L in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK040703-12
Application #
6127464
Study Section
Pathology A Study Section (PTHA)
Program Officer
Hirschman, Gladys H
Project Start
1989-01-01
Project End
2004-03-31
Budget Start
2000-05-01
Budget End
2001-03-31
Support Year
12
Fiscal Year
2000
Total Cost
$359,445
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Yao, Gang; Luo, Chong; Harvey, Michael et al. (2016) Disruption of polycystin-L causes hippocampal and thalamocortical hyperexcitability. Hum Mol Genet 25:448-58
Su, Xuefeng; Wu, Maoqing; Yao, Gang et al. (2015) Regulation of polycystin-1 ciliary trafficking by motifs at its C-terminus and polycystin-2 but not by cleavage at the GPS site. J Cell Sci 128:4063-73
Yao, Gang; Su, Xuefeng; Nguyen, Vy et al. (2014) Polycystin-1 regulates actin cytoskeleton organization and directional cell migration through a novel PC1-Pacsin 2-N-Wasp complex. Hum Mol Genet 23:2769-79
Yao, Gang; Luyten, Annouck; Takakura, Ayumi et al. (2013) The cytoplasmic protein Pacsin 2 in kidney development and injury repair. Kidney Int 83:426-37
Qin, Shan; Taglienti, Mary; Cai, Lei et al. (2012) c-Met and NF-ýýB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease. J Am Soc Nephrol 23:1309-18
Takakura, Ayumi; Nelson, Erik A; Haque, Nadeem et al. (2011) Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. Hum Mol Genet 20:4143-54
Luyten, Annouck; Su, Xuefeng; Gondela, Sarah et al. (2010) Aberrant regulation of planar cell polarity in polycystic kidney disease. J Am Soc Nephrol 21:1521-32
Qin, Shan; Taglienti, Mary; Nauli, Surya M et al. (2010) Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease. J Clin Invest 120:3617-28
Subramanian, Balajikarthick; Rudym, Darya; Cannizzaro, Chris et al. (2010) Tissue-engineered three-dimensional in vitro models for normal and diseased kidney. Tissue Eng Part A 16:2821-31
Takakura, Ayumi; Contrino, Leah; Zhou, Xiangzhi et al. (2009) Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum Mol Genet 18:2523-31

Showing the most recent 10 out of 39 publications